Large-scale testing (Phase 3)Active Not RecruitingNCT07214818What this trial is testingSGLT2 Inhibitors in Adult Primary Nephrotic SyndromeWho this might be right forNephrotic Syndrome Mansoura University 75
Early research (Phase 1)Looking for participantsNCT05521984What this trial is testingTargeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)Who this might be right forPediatric Brain TumorPediatric Solid Tumor Washington University School of Medicine 20
Post-approval studies (Phase 4)Study completedNCT06026787What this trial is testingClinical Value of Adding Dapagliflozin in Patients With Nephrotic SyndromeWho this might be right forNephrotic SyndromeSodium-Glucose Transporter 2 Inhibitors Ain Shams University 60
Not applicableStudy completedNCT07338331What this trial is testingComparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver DiseaseWho this might be right forDiabete Type 2Non Alcoholic Fatty Liver Galala University 80
Not applicableActive Not RecruitingNCT05890131What this trial is testingImplementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital StrategyWho this might be right forHeart Failure Morten Schou 5,996
Not applicableUnknownNCT04961931What this trial is testingEffect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney DiseaseWho this might be right forChronic Kidney Disease stage3 Medical University of Lodz 45
Early research (Phase 1)Looking for participantsNCT05960656What this trial is testingSGLTi, Hepatic Glucose Production and KetogenesisWho this might be right forType 2 Diabetes The University of Texas Health Science Center at San Antonio 30
Post-approval studies (Phase 4)UnknownNCT04796428What this trial is testingGliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation TrialWho this might be right forDiabetes Mellitus, Type 2 Center for Outcomes Research and Clinical Epidemiology, Italy 1,167
Post-approval studies (Phase 4)Study completedNCT03646292What this trial is testingAntidiabetic Drugs for Steatotic Liver DiseaseWho this might be right forMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more Yonsei University 51
Post-approval studies (Phase 4)Study completedNCT03226457What this trial is testingSGLT2 Inhibition in Combination With Diuretics in Heart FailureWho this might be right forHeart FailureType 2 Diabetes Mellitus University of Dundee 23
Not applicableNot Yet RecruitingNCT07334145What this trial is testingEffect of SGLT2 Inhibitors on Anemic CKD PatientsWho this might be right forAnemia in CKD Patients Sohag University 60
Not applicableLooking for participantsNCT06932081What this trial is testingAdult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i RegistryWho this might be right forAdult Congenital Heart DiseaseCongenital Heart DiseaseSystemic Right Ventricle+5 more Leiden University Medical Center 400
Not applicableActive Not RecruitingNCT06453577What this trial is testingPharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart FailureWho this might be right forAcute Decompensated Heart Failure Universität des Saarlandes 12
Not applicableUnknownNCT05477017What this trial is testingEvaluation of SGLT2-i Effectivness and Safety in Elderly Type 2 Diabetes PatientsWho this might be right forType2Diabetes University of Milan 800
Very early researchStudy completedNCT06812429What this trial is testingEffects of Sodium-Glucose Co-transporter 2 Inhibitors on InflammationWho this might be right forInflammation Washington University School of Medicine 6
Not applicableUnknownNCT05612269What this trial is testingSGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational StudyWho this might be right forCancerDiabetes Mellitus, Type 2Interleukin 6+1 more Ministry of Health, Saudi Arabia 200
Testing effectiveness (Phase 2)Looking for participantsNCT06929169What this trial is testingCardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized StudyWho this might be right forChronic Kidney Disease Requiring Hemodialysis Maximo Agustin Schiavone 80
Not applicableUnknownNCT06128096What this trial is testingThe Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD)Who this might be right forCoronary Artery Disease Clinical Research Centre, Malaysia 360
Post-approval studies (Phase 4)WithdrawnNCT02768220What this trial is testingThe Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End ProductsWho this might be right forSGLT-2 InhibitorsAdvanced Glycation End ProductsDiabetes Northwell Health
Testing effectiveness (Phase 2)Active Not RecruitingNCT06688123What this trial is testingEfficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes SubjectsWho this might be right forType 2 Diabetes Jiangsu HengRui Medicine Co., Ltd. 275